Profit

New drug pricing policy to boost profit of pharma firms: Kewal Handa

PUBLISHED ON: September 28, 2012 | Duration: 6 min, 01 sec

facebooktwitteremailkoo
loading..
While congratulating the government on moving away from a cost plus model of drug pricing, Kewal Handa, Industry Expert, & Former MD, Pfizer Ltd also says that pharma companies will see a very large impact on profitability because of the new drug pricing norms.
ALSO WATCH
Moderna Sues Pfizer Over Covid Vaccine

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com